These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19714261)

  • 1. Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors.
    Josan JS; Vagner J; Handl HL; Sankaranarayanan R; Gillies RJ; Hruby VJ
    Int J Pept Res Ther; 2008 Dec; 14(4):293-300. PubMed ID: 19714261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-specific targeting by heterobivalent ligands.
    Josan JS; Handl HL; Sankaranarayanan R; Xu L; Lynch RM; Vagner J; Mash EA; Hruby VJ; Gillies RJ
    Bioconjug Chem; 2011 Jul; 22(7):1270-8. PubMed ID: 21639139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
    Fernandes SM; Lee YS; Gillies RJ; Hruby VJ
    Bioorg Med Chem; 2014 Nov; 22(22):6360-5. PubMed ID: 25438759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).
    Handl HL; Sankaranarayanan R; Josan JS; Vagner J; Mash EA; Gillies RJ; Hruby VJ
    Bioconjug Chem; 2007; 18(4):1101-9. PubMed ID: 17591746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced targeting with heterobivalent ligands.
    Xu L; Vagner J; Josan J; Lynch RM; Morse DL; Baggett B; Han H; Mash EA; Hruby VJ; Gillies RJ
    Mol Cancer Ther; 2009 Aug; 8(8):2356-65. PubMed ID: 19671749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterobivalent ligands target cell-surface receptor combinations in vivo.
    Xu L; Josan JS; Vagner J; Caplan MR; Hruby VJ; Mash EA; Lynch RM; Morse DL; Gillies RJ
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21295-300. PubMed ID: 23236171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC
    Lindner S; Fiedler L; Wängler B; Bartenstein P; Schirrmacher R; Wängler C
    Eur J Med Chem; 2018 Jul; 155():84-95. PubMed ID: 29864700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA
    Cheng X; Hübner R; von Kiedrowski V; Fricker G; Schirrmacher R; Wängler C; Wängler B
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Prediction of Multivalent Ligand-Receptor Binding Affinities for Influenza, Cholera, and Anthrax Inhibition.
    Liese S; Netz RR
    ACS Nano; 2018 May; 12(5):4140-4147. PubMed ID: 29474056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.
    Xu L; Vagner J; Alleti R; Rao V; Jagadish B; Morse DL; Hruby VJ; Gillies RJ; Mash EA
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2489-92. PubMed ID: 20304640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rigid linkers for bioactive peptides.
    Vagner J; Handl HL; Monguchi Y; Jana U; Begay LJ; Mash EA; Hruby VJ; Gillies RJ
    Bioconjug Chem; 2006; 17(6):1545-50. PubMed ID: 17105235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.
    Vagner J; Xu L; Handl HL; Josan JS; Morse DL; Mash EA; Gillies RJ; Hruby VJ
    Angew Chem Int Ed Engl; 2008; 47(9):1685-8. PubMed ID: 18205159
    [No Abstract]   [Full Text] [Related]  

  • 13. Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers.
    Bailly T; Bodin S; Goncalves V; Denat F; Morgat C; Prignon A; Valverde IE
    ACS Med Chem Lett; 2023 May; 14(5):636-644. PubMed ID: 37197474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.
    Peschel A; Cardoso FC; Walker AA; Durek T; Stone MRL; Braga Emidio N; Dawson PE; Muttenthaler M; King GF
    J Med Chem; 2020 Nov; 63(21):12773-12785. PubMed ID: 33078946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.
    Lee YS; Fernandes S; Kulkarani V; Mayorov A; Davis P; Ma SW; Brown K; Gillies RJ; Lai J; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4080-4. PubMed ID: 20547453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamics of multivalent interactions: influence of the linker.
    Kane RS
    Langmuir; 2010 Jun; 26(11):8636-40. PubMed ID: 20131760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.
    Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ
    J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT
    Poulie CBM; Liu N; Jensen AA; Bunch L
    J Med Chem; 2020 Sep; 63(17):9928-9949. PubMed ID: 32815361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy.
    Judmann B; Braun D; Wängler B; Schirrmacher R; Fricker G; Wängler C
    Pharmaceuticals (Basel); 2020 Jul; 13(8):. PubMed ID: 32751666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L; Panico MR; Caracó C; Zannetti A; Del Vecchio S; Di Nuzzo C; Arra C; Morelli G; Tesauro D; De Luca S; Pedone C; Salvatore M
    Biopolymers; 2002; 66(6):370-80. PubMed ID: 12658724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.